Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.7300 (-0.56%) ($17.7100 - $18.0300) on Tue. Dec. 31, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.1% (three month average) | RSI | 24 | Latest Price | $17.7300(-0.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(50%) IWC(49%) XBI(49%) | Factors Impacting HALO price | HALO will decline at least -1.05% in a week (0% probabilities). VIXM(-38%) VXX(-20%) UUP(-7%) TLT(-3%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.05% (StdDev 2.1%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
1 - 5 Day Possible Target | $13.32(-24.87%) | Resistance Level | $18.62 | 5 Day Moving Average | $18.05(-1.77%) | 10 Day Moving Average | $18.25(-2.85%) | 20 Day Moving Average | $18.62(-4.78%) | To recent high | -9.2% | To recent low | 18.8% | Market Cap | $2.423b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |